Results 301 to 310 of about 20,872,194 (388)

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Prognostic impact of spatial niches in prostate cancer. [PDF]

open access: yesSci Rep
Schneider F   +10 more
europepmc   +1 more source

Simulation results of visibility variation across floors in the shopping center.

open access: green
Yunhao Jiang (21897499)   +6 more
openalex   +1 more source

Practice-Based Versus Telemedicine-Based Collaborative Care for Depression in Rural Federally Qualified Health Centers: A Pragmatic Randomized Comparative Effectiveness Trial

open access: green, 2013
John C. Fortney   +9 more
openalex   +2 more sources

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Interruptive versus Non-Interruptive Reminders for Statin tHerApy in Primary Care (INIRSHA-PC): protocol and statistical analysis plan for a randomised clinical trial. [PDF]

open access: yesBMJ Open
Wright AP   +10 more
europepmc   +1 more source

Modifications made to the chronic conditions in the Centers for Medicare and Medicaid Services Chronic Conditions Data Warehouse.

open access: green
Atinuke G. Oyinbo (17527939)   +7 more
openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

Conditions to assess client-centered implant removal, operational definition, and level for data collection.

open access: green
Celia Karp (9236356)   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy